doi: 10.1021/acsenvironau.4c00055, 273
Some of the major players operating in the market are Novo Nordisk A/S, Lilly, Sanofi, AstraZeneca, Pfizer Inc., Boehringer Ingelheim International GmbH, Amgen Inc., ZEALAND PHARMA, Merck & Co., Inc., Hanmi Pharm.Co.,Ltd
GLP-1 receptor agonist medications like semaglutide and tirzepatide mimic this hormone at therapeutic levels, creating a powerful, sustained effect that your body's natural GLP-1 alone can't achieve
The bottom line: if you are purchasing "oral tirzepatide" in early February of this year, you are purchasing an unregulated product with no clinical evidence of efficacy, no quality assurance, and potential legal and health risks
It slows gastric emptying, which can lead to a decrease in hunger and an increase in satiety after meals